TrovaGene, Inc. (TROV) was a big mover last session, as the company saw its shares rise over 9% on the day. The move came on solid volume too with far more shares changing hands than in a normal session. This breaks the recent trend of the company, as the stock is now trading above the volatile price range of $3.00 to $4.44 in the past one-month time frame.
The company has seen one positive revision in the past 30 days and its Zacks Consensus Estimate moved higher over the same time frame, suggesting that more solid trading could be ahead for TrovaGene. So make sure to keep an eye on this stock going forward to see if yesterday’s jump can turn into more strength down the road.
TrovaGene currently has a Zacks Rank #2 (Buy) while its Earnings ESP is 0.00%.
Other stocks to consider in the biomedical/gene industry include Cambrex Corporation. (CBM), Gilead Sciences Inc. (GILD) and China Biologic Products, Inc. (CBPO). All of these sport a Zacks Rank #1 (Strong Buy).
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report >>
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
To read this article on Zacks.com click here.
Get all Zacks Research Reports and be alerted to fast-breaking buy and sell opportunities every trading day.
Be the first to comment